Srs Labs Inc - Current report filing (8-K)
November 06 2007 - 4:36PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of
earliest event reported):
November 6, 2007
SRS LABS,
INC.
(Exact Name of registrant
as specified in its charter)
Delaware
|
|
0-21123
|
|
33-0714264
|
(State or other
jurisdiction of
|
|
(Commission File
Number)
|
|
(IRS Employer
|
incorporation)
|
|
|
|
Identification No.)
|
2909 Daimler Street
Santa Ana, California
|
|
92705
|
(Address of principal
executive offices)
|
|
(Zip Code)
|
Registrants
telephone number, including area code:
(949) 442-1070
Not Applicable
(Former name or former
address, if changed since last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2 (b))
o
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 2.02. Results
of Operation and Financial Condition.
The information being furnished in this Item 2.02 and
in Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the Exchange Act), or
incorporated by reference in any filing under the Securities Act of 1933, as
amended or the Exchange Act, except as shall be expressly set forth by specific
reference in such filing.
On November 6, 2007, SRS Labs, Inc. issued a press
release announcing its operating results for the third quarter and nine months
ended September 30, 2007. A copy of the
press release is attached hereto as Exhibit 99.1 and incorporated by reference
herein.
Item 8.01. Other Events.
On November 6, 2007, the Company announced that the
Companys Board of Directors has approved a stock repurchase program. Under the stock repurchase program, the
Company may acquire up to $10.0 million of the Companys outstanding common
stock. The stock repurchase program will commence November 12, 2007 and will
continue for a six month period.
Purchases may be made from time to time in the open market, in block
purchases or in privately negotiated transactions, depending on market
conditions, share price and other factors.
Item 9.01. Financial Statements and Exhibits.
Exhibit No.
|
|
Description
|
99.1
|
|
Press Release dated November 6, 2007.
|
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
|
SRS LABS, INC.,
|
|
a Delaware corporation
|
|
|
Date: November 6, 2007
|
By:
|
/S/ THOMAS C.K. YUEN
|
|
|
|
Thomas C.K. Yuen
|
|
|
Chairman of the
Board and
|
|
|
Chief Executive
Officer
|
2
Srs Labs (NASDAQ:SRSL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Srs Labs (NASDAQ:SRSL)
Historical Stock Chart
From Jul 2023 to Jul 2024